Advisornet Financial’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$135K Buy
108,769
+32,105
+42% +$39.8K 0.01% 670
2025
Q1
$90.5K Buy
76,664
+11,895
+18% +$14K 0.01% 755
2024
Q4
$119K Buy
64,769
+4,563
+8% +$8.35K 0.01% 632
2024
Q3
$102K Buy
60,206
+16,888
+39% +$28.7K 0.01% 695
2024
Q2
$59.3K Buy
43,318
+6,473
+18% +$8.87K 0.01% 767
2024
Q1
$138K Buy
36,845
+1,325
+4% +$4.97K 0.01% 548
2023
Q4
$348K Buy
35,520
+6,577
+23% +$64.5K 0.03% 378
2023
Q3
$242K Buy
28,943
+34
+0.1% +$284 0.02% 416
2023
Q2
$384K Buy
28,909
+197
+0.7% +$2.62K 0.03% 354
2023
Q1
$332K Buy
28,712
+125
+0.4% +$1.45K 0.03% 364
2022
Q4
$234K Buy
28,587
+525
+2% +$4.3K 0.02% 443
2022
Q3
$163K Hold
28,062
0.02% 545
2022
Q2
$124K Buy
28,062
+1,390
+5% +$6.14K 0.01% 608
2022
Q1
$243K Hold
26,672
0.02% 509
2021
Q4
$546K Sell
26,672
-1,180
-4% -$24.2K 0.03% 383
2021
Q3
$712K Sell
27,852
-700
-2% -$17.9K 0.05% 300
2021
Q2
$998K Sell
28,552
-490
-2% -$17.1K 0.07% 252
2021
Q1
$967K Sell
29,042
-4,573
-14% -$152K 0.07% 245
2020
Q4
$872K Sell
33,615
-16,405
-33% -$426K 0.07% 239
2020
Q3
$494K Sell
50,020
-7,930
-14% -$78.3K 0.04% 337
2020
Q2
$200K Buy
57,950
+19,000
+49% +$65.6K 0.02% 494
2020
Q1
$119K Buy
38,950
+2,500
+7% +$7.64K 0.01% 570
2019
Q4
$187K Hold
36,450
0.02% 516
2019
Q3
$188K Buy
36,450
+5,500
+18% +$28.4K 0.02% 524
2019
Q2
$187K Buy
30,950
+10,550
+52% +$63.7K 0.02% 460
2019
Q1
$147K Hold
20,400
0.02% 475
2018
Q4
$151K Hold
20,400
0.02% 438
2018
Q3
$110K Hold
20,400
0.01% 535
2018
Q2
$72K Buy
20,400
+7,800
+62% +$27.5K 0.01% 610
2018
Q1
$26K Buy
12,600
+10,000
+385% +$20.6K ﹤0.01% 871
2017
Q4
$7K Buy
+2,600
New +$7K ﹤0.01% 1070